DEA/OD/ODE
Introduction:
Benzodiazepines are a class of drugs that
produce central nervous system (CNS) depression and that are
most commonly used to treat insomnia and anxiety. There is the
potential for dependence on and abuse of benzodiazepines
particularly by individuals with a history of multi-substance
abuse. Alprazolam (e.g., Xanax), lorazepam (e.g., Ativan),
clonazepam (e.g., Klonopin), diazepam (e.g., Valium), and
temazepam (e.g., Restoril) are the five most prescribed, as well
as the most frequently encountered benzodiazepines on the
illicit market.
Licit Uses:
Chemistry and
Pharmacology:
All benzodiazepines are composed of a benzene
ring and a seven-member diazepine ring. Most benzodiazepines
also possess a phenyl ring attached at the 5-position of the
diazepine ring. Small modifications of this basic structure
account for the varied pharmacologic effects of these drugs.
Benzodiazepines produce CNS depression by
enhancing the effects of the major inhibitory neurotransmitter,
gamma-aminobutyric acid, thereby decreasing brain activity.
Benzodiazepines are classified by their duration of action that
ranges from less than 6 hours to more than 24 hours.
Some benzodiazepines have active metabolites that prolong their
effects.
Adverse effects include increased reaction
time, motor incoordination, anterograde amnesia, slurred speech,
restlessness, delirium, aggression, depression, hallucinations,
and paranoia. Unlike barbiturates, large doses of
benzodiazepines are rarely fatal unless combined with other CNS
depressant drugs, such as alcohol or opioids. Flumazenil can be
administered by injection to reverse the adverse effects of
benzodiazepines.
Tolerance often develops after long term use
requiring larger doses to achieve the desired effect. Physical
and psychological dependence may develop, whether taken under a
doctor’s orders or used illicitly. Withdrawal symptoms, the
severity of which is dependent on the dose, duration of use, and
particular drug used, include anxiety, insomnia, dysphoria,
tremors, and seizures. Withdrawal can be precipitated by the
administration of flumazenil to individuals dependent upon
benzodiazepines.
Illicit Uses:
Benzodiazepines, particularly those having a
rapid onset, are abused to produce a euphoric effect often
described as a "high." Abuse of benzodiazepines is
often associated with multiple-substance abuse. Diazepam and
alprazolam are used in combination with methadone to potentiate
methadone’s euphoric effect. Cocaine addicts use
benzodiazepines to relieve the side effects (e.g., irritability
and agitation) associated with cocaine binges. Benzodiazepines
are also used to augment alcohol’s effects and modulate
withdrawal states. The doses of benzodiazepines taken by abusers
are usually in excess of the recommended therapeutic dose.
Benzodiazepines have been used to facilitate sexual assault.
Illicit Distribution:
Individuals abusing benzodiazepines obtain
them by getting prescriptions from several doctors, forging
prescriptions, or buying diverted pharmaceutical products on the
illicit market. Domestic and foreign products are found in the
illicit market. Alprazolam is one of the top three prescription
drugs illegally encountered. In 2006, as reported by the
National Forensic Laboratory Information System, state and local
drug laboratories analyzed 24,057 alprazolam, 6,360
clonazepam, 5,886 diazepam, 1,444 lorazepam, and
333 temazepam exhibits. In 2006, the DEA drug laboratories,
as reported in the System to Retrieve Information from Drug
Evidence system, analyzed 384 alprazolam, 107 clonazepam,
179 diazepam, 60 lorazepam, and 22 temazepam
exhibits.
Control Status:
Benzodiazepines are classified as schedule IV
depressants under the Controlled Substances Act. Flunitrazepam
is unique among the benzodiazepines in being placed in schedule
IV but having schedule I penalties.
Comments and additional information are welcomed by the
Drug and Chemical Evaluation Section, FAX 202-353-1263 or
telephone 202-307-7183.